The Australian: Race Oncology doses first patient in RC220 Phase 1 solid tumour trial

The Australian reports Race Oncology has achieved a major milestone, as the company has safely and successfully dosed its first patients for its Phase 1 clinical trial in advanced solid tumours.

Read the full report here.